digoxin
Showing 1 - 25 of 362
Healthy Trial in Salt Lake City (LY3537982, Digoxin, Rosuvastatin)
Not yet recruiting
- Healthy
- LY3537982
- +3 more
-
Salt Lake City, UtahICON Early Clinical & Bioanalytical Solutions
Oct 27, 2023
Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)
Recruiting
- Drug Drug Interaction
- Digoxin
- +4 more
-
Guangzhou, ChinaThe First Affiliated Hospital of Guangzhou University of Chinese
Jul 13, 2023
Healthy Volunteers Trial (Supaglutide injection, Digoxin, Metformin)
Not yet recruiting
- Healthy Volunteers
- Supaglutide injection
- +2 more
- (no location specified)
Jan 20, 2023
Healthy Volunteers Trial in Beijing (GP681, Rosuvastatin, Digoxin)
Recruiting
- Healthy Volunteers
- GP681
- +4 more
-
Beijing, ChinaChina-Japan Friendship Hospital
Mar 28, 2023
Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)
Not yet recruiting
- Overweight Subjects
- Obese Subjects
- metformin
- +4 more
-
Beijing, Beijing, ChinaAerospace Center Hospital
Apr 4, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Plantar Wart Trial (intralesional combined digoxin and furosemide, intralesional injection of 5- Fluorouracil, intralesional
Not yet recruiting
- Plantar Wart
- intralesional combined digoxin and furosemide
- +2 more
- (no location specified)
Oct 25, 2022
Healthy Participants Trial in Daytona Beach (AMG 510, Digoxin)
Completed
- Healthy Participants
- AMG 510
- Digoxin
-
Daytona Beach, FloridaCovance Clinical Research Unit, Inc
Oct 25, 2022
COPD Exacerbation, COPD Trial in Uppsala (EP395 (Part A and B), Verapamil (Part A), Midazolam (Part B))
Recruiting
- Chronic Obstructive Pulmonary Disease Exacerbation
- COPD
- EP395 (Part A and B)
- +3 more
-
Uppsala, SwedenClinical Trial Consultants AB
Nov 1, 2023
Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)
Not yet recruiting
- Non-Medullary Thyroid Carcinoma
- Digoxin tablet
- (no location specified)
Aug 20, 2022
Atrial Fibrillation, Left Atrial Rhythm Trial in Monastir (Digoxin 0.25 mg, Bisoprolol)
Recruiting
- Atrial Fibrillation
- Left Atrial Rhythm
- Digoxin 0.25 mg
- Bisoprolol
-
Monastir, TunisiaFattouma Bourguiba University hospital
Sep 14, 2022
Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)
Recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- TPX-0005
- +3 more
-
Canton, OhioGabrail Cancer Research Center
Apr 25, 2023
Healthy Male Trial in Shanghai (D-1553)
Active, not recruiting
- Healthy Male
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Oct 23, 2023
Acute Heart Failure Trial in Hammam sousse, Monastir (Digoxin, Placebo)
Recruiting
- Acute Heart Failure
- Digoxin
- Placebo
-
Hammam sousse, Sousse, Tunisia
- +1 more
Jun 20, 2022
Healthy Volunteers Trial (CC-92480, Rifampin, Itraconazole)
Recruiting
- Healthy Volunteers
- CC-92480
- +4 more
-
Dallas, TexasCovance Clinical Research Unit - Dallas
Oct 25, 2022
Solid Tumor Trial in Shanghai (AB-106, digoxin)
Completed
- Solid Tumor
- AB-106, digoxin
-
Shanghai, ChinaShanghai Xuhui Central Hospital
May 5, 2022
Healthy Volunteers Study Trial in Montreal (AT-527 + digoxin)
Completed
- Healthy Volunteers Study
- AT-527 + digoxin
-
Montreal, Quebec, CanadaAtea Study Site
Feb 23, 2022
Chronic Hepatitis B Trial (HRS5091 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Chronic Hepatitis B
- HRS5091 Tablets
- +6 more
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Dec 22, 2022
Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg)
Recruiting
- Rheumatoid Arthritis
- Placebo
- +2 more
-
Shibīn Al Kawm, EgyptMenoufia University Hospital
Apr 5, 2022
Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)
Not yet recruiting
- Polycythemia; Familial
- +5 more
- Digoxin
- (no location specified)
Feb 2, 2022